Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Macrogenics (MGNX) Inventory Average (2021 - 2025)

Historic Inventory Average for Macrogenics (MGNX) over the last 5 years, with Q3 2025 value amounting to $9.0 million.

  • Macrogenics' Inventory Average rose 31523.29% to $9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.0 million, marking a year-over-year increase of 31523.29%. This contributed to the annual value of $1.3 million for FY2023, which is 5423.87% down from last year.
  • According to the latest figures from Q3 2025, Macrogenics' Inventory Average is $9.0 million, which was up 31523.29% from $9.4 million recorded in Q2 2025.
  • Macrogenics' 5-year Inventory Average high stood at $9.4 million for Q2 2025, and its period low was $1.1 million during Q4 2023.
  • Its 5-year average for Inventory Average is $3.5 million, with a median of $2.1 million in 2022.
  • As far as peak fluctuations go, Macrogenics' Inventory Average crashed by 6967.85% in 2022, and later soared by 69246.72% in 2025.
  • Quarter analysis of 5 years shows Macrogenics' Inventory Average stood at $4.2 million in 2021, then crashed by 69.68% to $1.3 million in 2022, then fell by 9.85% to $1.1 million in 2023, then surged by 90.6% to $2.2 million in 2024, then skyrocketed by 315.23% to $9.0 million in 2025.
  • Its last three reported values are $9.0 million in Q3 2025, $9.4 million for Q2 2025, and $2.2 million during Q3 2024.